"The consensus price target fell 23% to AU$3.98, with the analysts clearly concerned about the company following the weaker revenue and earnings outlook"
"The most optimistic Mesoblast analyst has a price target of AU$5.80 per share, while the most pessimistic values it at AU$2.15"The consensus of $3.98 seems like an average of the two prices of $5.80 & $2.15 = 3.975.
The Bell Potter report which appears to be the $5.80 per share didn't seem concerned about the company earnings outlook, quite the contrary, that only leave the $2.15 report... hmmm where is that one?
Bell Potter Daily Pack 16 April 2020, page-22
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.40 |
Change
-0.065(4.44%) |
Mkt cap ! $1.581B | |||
| Open | High | Low | Value | Volume |
| $1.45 | $1.46 | $1.37 | $6.439M | 4.588M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1490 | $1.40 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.40 | 2709 | 4 |
View Market Depth
| Last trade - 13.39pm 09/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |